Showing results (41-50 of 98) with videos related to
Sort By:
Pageof 10
JAMA Neurology|August 19, 2014
Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxiaBrent L Fogel, Hane Lee, Joshua L Deignan, et al.Annals of Neurology|December 14, 2011
A gene expression phenotype in lymphocytes from Friedreich ataxia patientsGiovanni Coppola, Ryan Burnett, Susan Perlman, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 18, 2025
Venglustat in GM2 gangliosidoses and related disorders: Results of the AMETHIST randomized controlled and basket trialsCynthia J Tifft, Isabela Batsu, Roberto Giugliani, et al.Cerebellum (London, England)|September 1, 2025
Content Validity of the Spinocerebellar Ataxia Composite Score as a Measure of Disease Progression in Patients with Spinocerebellar AtaxiaMichele Potashman, Maggie Heinrich, Katja Rudell, et al.Movement Disorders : Official Journal of the Movement Disorder Society|August 23, 2021
Gait Variability in Spinocerebellar Ataxia Assessed Using Wearable Inertial SensorsVrutangkumar V Shah, Roberto Rodriguez-Labrada, Fay B Horak, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2010
Measuring the rate of progression in Friedreich ataxia: implications for clinical trial designLisa S Friedman, Jennifer M Farmer, Susan Perlman, et al.Neurology. Genetics|June 26, 2020
Prevalence of RFC1-mediated spinocerebellar ataxia in a North American ataxia cohortDona Aboud Syriani, Darice Wong, Sameer Andani, et al.Journal of Huntington'S Disease|July 22, 2025
Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's diseaseJennifer Petrillo, Ruta Sawant, Rebecca Rogers, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2024
Digital Measures of Postural Sway Quantify Balance Deficits in Spinocerebellar AtaxiaVrutangkumar V Shah, Daniel Muzyka, Adam Jagodinsky, et al.The Lancet. Neurology|February 11, 2014
Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trialPhillip A Low, David Robertson, Sid Gilman, et al.Pageof 10